136 related articles for article (PubMed ID: 21958499)
1. Paediatric oncology: are there ways to bend the costs?
Calaminus G
Lancet Oncol; 2011 Sep; 12(10):927-8. PubMed ID: 21958499
[No Abstract] [Full Text] [Related]
2. Analysis of media reporting of The Lancet Oncology Commission.
Sullivan R; Purushotham A
Lancet Oncol; 2012 Jan; 13(1):12-3. PubMed ID: 22225716
[No Abstract] [Full Text] [Related]
3. Affordable cancer care.
Brábek J; Fernandes M
Lancet Oncol; 2012 Jan; 13(1):e2-3. PubMed ID: 22225720
[No Abstract] [Full Text] [Related]
4. What price cure?
Kunkler I
Lancet Oncol; 2012 Jan; 13(1):e2. PubMed ID: 22225721
[No Abstract] [Full Text] [Related]
5. Drivers of the cost of cancer care.
Bergstrom R
Lancet Oncol; 2012 Jan; 13(1):14-5. PubMed ID: 22225717
[No Abstract] [Full Text] [Related]
6. Challenges related to palliative care.
Kaasa S; Payne S; Sjøgren P
Lancet Oncol; 2011 Sep; 12(10):925-7. PubMed ID: 21958498
[No Abstract] [Full Text] [Related]
7. Caring for patients with haematological malignancies.
Foà R; Jaeger U
Lancet Oncol; 2011 Sep; 12(10):928-9. PubMed ID: 21958500
[No Abstract] [Full Text] [Related]
8. Striking a balance between idealism and fatalism.
Collingridge D
Lancet Oncol; 2011 Sep; 12(10):923-4. PubMed ID: 21958496
[No Abstract] [Full Text] [Related]
9. The opportunity cost of cancer care: a statement from NICE.
Rawlins MD; Chalkidou K
Lancet Oncol; 2011 Sep; 12(10):931-2. PubMed ID: 21958502
[No Abstract] [Full Text] [Related]
10. Cancer care after the National Health Service reforms.
Baron J
Lancet Oncol; 2012 Jan; 13(1):15-6. PubMed ID: 22225718
[No Abstract] [Full Text] [Related]
11. Regulators, payers, and prescribers: can we fill the gaps?
Pignatti F; Luria X; Abadie E; Eichler HG
Lancet Oncol; 2011 Sep; 12(10):930-1. PubMed ID: 21958501
[No Abstract] [Full Text] [Related]
12. …And the only side-effects are good ones.
Ornish D
Lancet Oncol; 2011 Sep; 12(10):924-5. PubMed ID: 21958497
[No Abstract] [Full Text] [Related]
13. Delivering affordable cancer care in high-income countries.
Sullivan R; Peppercorn J; Sikora K; Zalcberg J; Meropol NJ; Amir E; Khayat D; Boyle P; Autier P; Tannock IF; Fojo T; Siderov J; Williamson S; Camporesi S; McVie JG; Purushotham AD; Naredi P; Eggermont A; Brennan MF; Steinberg ML; De Ridder M; McCloskey SA; Verellen D; Roberts T; Storme G; Hicks RJ; Ell PJ; Hirsch BR; Carbone DP; Schulman KA; Catchpole P; Taylor D; Geissler J; Brinker NG; Meltzer D; Kerr D; Aapro M
Lancet Oncol; 2011 Sep; 12(10):933-80. PubMed ID: 21958503
[TBL] [Abstract][Full Text] [Related]
14. UK Government urged to recognise post-COVID-19 cancer backlog.
Wilkinson E
Lancet Oncol; 2021 Jul; 22(7):910. PubMed ID: 34090554
[No Abstract] [Full Text] [Related]
15. How the Affordable Care Act Has Affected Cancer Care in the United States: Has Value for Cancer Patients Improved?
Schleicher SM; Wood NM; Lee S; Feeley TW
Oncology (Williston Park); 2016 May; 30(5):468-74. PubMed ID: 27188679
[No Abstract] [Full Text] [Related]
16. Financial toxicity in clinical care today: a "menu without prices"1.
Currow D; Aranda S
Med J Aust; 2016 Jun; 204(11):397. PubMed ID: 27318391
[No Abstract] [Full Text] [Related]
17. Improving health in the United States: Oral health is key to overall health.
Chalmers NI; Wislar JS; Boynes SG; Doherty M; Nový BB
J Am Dent Assoc; 2017 Jul; 148(7):477-480. PubMed ID: 28651703
[No Abstract] [Full Text] [Related]
18. US Cancer Care System Ill-Equipped to Deliver New Advances to Patients.
Rappaport M
J Oncol Pract; 2016 May; 12(5):397. PubMed ID: 27170686
[No Abstract] [Full Text] [Related]
19. Funding Cancer Quality Improvement: Payer's Perspective.
Schumacher H
J Oncol Pract; 2015 May; 11(3):180-1. PubMed ID: 25804984
[No Abstract] [Full Text] [Related]
20. Measuring the costs of cancer treatment – what model should we use?
Weller D
Eur J Cancer Care (Engl); 2015 May; 24(3):283-5. PubMed ID: 25876018
[No Abstract] [Full Text] [Related]
[Next] [New Search]
